Telomere Attrition Mitigation is the biological and clinical strategy focused on slowing the rate at which telomeres—the protective caps on the ends of chromosomes—shorten with each cell division and exposure to oxidative stress. Telomere shortening is a well-established marker and mechanism of cellular senescence and biological aging. Mitigation efforts are aimed at preserving telomere length and function to maintain genomic stability and extend the replicative capacity of cells.
Origin
This term is directly rooted in the discovery of telomeres and the enzyme telomerase, which provided a molecular explanation for the Hayflick limit and cellular aging. The clinical relevance became clear when short telomere length was correlated with numerous age-related diseases and reduced lifespan. Mitigation strategies are a direct application of this molecular understanding to the goal of healthspan extension.
Mechanism
Mitigation primarily involves reducing the rate of oxidative stress and chronic inflammation, which are major environmental drivers of telomere erosion. It also includes interventions aimed at upregulating the activity of the telomerase enzyme in specific cell types, which adds repetitive DNA sequences back onto the telomere ends. By preserving the protective cap, the cell avoids triggering DNA damage response pathways that lead to cell cycle arrest or senescence, thereby sustaining tissue renewal.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.